Balanced news tone
News Sentiment
BSX sentiment intelligence
Boston Scientific Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-2.1% over one week, -2.7% over four weeks, trend inactive, and below fair value.
Boston Scientific (BSX) Recalls Endoscopy Devices, Is The Stock A Bargain?
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Boston Scientific (BSX) Recalls Endoscopy Devices, Is The Stock A Bargain?
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 17 Jul 2026 14:33
- Source
- simplywall.st
Boston Scientific (BSX): Buy, Sell, or Hold Post Q1 Earnings?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Jul 2026 15:01
- Source
- Market source
Boston Scientific (BSX) Stock Looks Cheap On Earnings While Returns Stay Weak
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 Jul 2026 04:10
- Source
- simplywall.st
Boston Scientific Corporation (BSX) Is A Stock To Buy According To D. E. Shaw
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 12 Jul 2026 14:04
- Source
- Market source
Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Market source
Boston Scientific: The Time Has Come To Catch This Falling Knife (NYSE:BSX)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Seeking Alpha
Boston Scientific (BSX) Stock Could Be A Bargain After A 57% Slump
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 06 Jul 2026 07:00
- Source
- Market source
Boston Scientific’s Quarterly Earnings Preview: What You Need to Know
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Jul 2026 07:00
- Source
- Market source
Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Market source
Boston Scientific's Fall From Penthouse To Doghouse Creates A Value Opportunity (NYSE:BSX)
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- Seeking Alpha
How a Targeted Valve Recall and Watchman Questions at Boston Scientific (BSX) Have Changed Its Investment Story
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 24 Jun 2026 07:00
- Source
- Market source
Boston Scientific Stock Decline 2026: Guidance Cuts and Analyst Outlook - News and Statistics
- Tone
- Negative 18/100
- Event
- Guidance
- Published
- 12 Jun 2026 07:00
- Source
- IndexBox
Boston Scientific (BSX) Stock Moves -1.27%: What You Should Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 07:00
- Source
- Market source
Boston Scientific Corp. stock (US10117L1017): Indiana expansion and sector backdrop in focus
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- ad-hoc-news.de
Boston Scientific (NYSE: BSX) CEO gifts 386,755 shares to irrevocable trust
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Stock Titan
Spotting Winners: Boston Scientific (NYSE:BSX) And Medical Devices & Supplies - Diversified Stocks In Q1
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Market source
Boston Scientific Corp. stock (US10117L1017): Wolfe Research downgrade in focus as shares trade near
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 31 May 2026 07:00
- Source
- ad-hoc-news.de
Boston Scientific (BSX) Shares Drop 10% Amid Demand Slowdown for WATCHMAN Implant
- Tone
- Neutral 50/100
- Event
- Macro sensitivity
- Published
- 27 May 2026 07:00
- Source
- GuruFocus
Boston Scientific (NYSE: BSX) director adds 4,450 company shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- Stock Titan
Boston Scientific enters into $2 billion accelerated share repurchase agreement
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 18 May 2026 07:00
- Source
- PR Newswire
Boston Scientific stock hits 52-week low at $53.10 By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 May 2026 07:00
- Source
- Investing.com Nigeria
Boston Scientific Corporation (BSX) Stock Analysis: A Promising 57.96% Potential Upside
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- DirectorsTalk Interviews
Boston Scientific Corp (BSX) Stock Down 4.7% -- Now Undervalued? GF Score: 84/100
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 May 2026 07:00
- Source
- GuruFocus
Fund Update: 543,460 BOSTON SCIENTIFIC (BSX) Shares Added to Mawer Investment Management Ltd. Portfolio
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2026 07:00
- Source
- Moomoo
Boston Scientific maps out May conference appearance, July 29 Q2 call
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 May 2026 07:00
- Source
- Stock Titan
Boston Scientific dives after disappointing clinical trial results
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 31 Mar 2026 07:00
- Source
- medwatch.com
BSX Shareholder Alert: Boston Scientific Corporation Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm
- Tone
- Negative 18/100
- Event
- Regulatory and legal
- Published
- 24 Mar 2026 07:00
- Source
- PR Newswire
Boston Scientific stock hits 52-week low at 68.19 USD By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Mar 2026 15:46
- Source
- Investing.com Nigeria
Boston Scientific Recall And Lawsuits Test Earnings Power And Capital Plans
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 07 Mar 2026 08:00
- Source
- Market source
Boston Scientific’s shares tumble 18% despite strong FY25 growth
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 05 Feb 2026 08:00
- Source
- Medical Device Network